Share on LinkedInShare on LinkedIn

ARTICLE · 11 JUNE 2013

Boosting capital raisings for mid/small caps on Australian Securities Exchange

Given the size of most ASX-listed Life Sciences companies, this recent ASX amendment is very significant for the sector.

AustraliaFinance and Banking

MSCs have a market capitalisation of $300 million or less and are not included in the S&P/ASX 300 Index.

Recently, the Australian Securities Exchange (ASX) amended its Listing Rules to enhance the capital raising environment for mid/small cap companies (MSC) currently listed on ASX. The most significant change enables MSCs to seek a mandate from shareholders to issue an additional 10% of the issued capital of the company without further approval. Given the size of most ASX-listed Life Sciences companies, this change is very significant for the sector.

This article briefly looks at:

  • What exactly is the amendment?
  • What are the benefits of the amendment?
  • Is there devil in the detail?

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from